Literature DB >> 22965277

Benchmarking to improve the quality of cystic fibrosis care.

Michael S Schechter1.   

Abstract

PURPOSE OF REVIEW: Benchmarking involves the ascertainment of healthcare programs with most favorable outcomes as a means to identify and spread effective strategies for delivery of care. The recent interest in the development of patient registries for patients with cystic fibrosis (CF) has been fueled in part by an interest in using them to facilitate benchmarking. This review summarizes reports of how benchmarking has been operationalized in attempts to improve CF care. RECENT
FINDINGS: Although certain goals of benchmarking can be accomplished with an exclusive focus on registry data analysis, benchmarking programs in Germany and the United States have supplemented these data analyses with exploratory interactions and discussions to better understand successful approaches to care and encourage their spread throughout the care network.
SUMMARY: Benchmarking allows the discovery and facilitates the spread of effective approaches to care. It provides a pragmatic alternative to traditional research methods such as randomized controlled trials, providing insights into methods that optimize delivery of care and allowing judgments about the relative effectiveness of different therapeutic approaches.

Entities:  

Mesh:

Year:  2012        PMID: 22965277     DOI: 10.1097/MCP.0b013e328358d533

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  5 in total

1.  Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis.

Authors:  Thida Ong; Frankline M Onchiri; Maria T Britto; Sonya L Heltshe; Larry G Kessler; Michael Seid; Bonnie W Ramsey
Journal:  J Cyst Fibros       Date:  2021-08-26       Impact factor: 5.482

Review 2.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

3.  Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?

Authors:  Julia Anne Nightingale; Clive Osmond
Journal:  J Cyst Fibros       Date:  2017-04-24       Impact factor: 5.482

4.  Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis.

Authors:  Astrid Fidika; Marion Herle; Lutz Goldbeck
Journal:  BMC Pulm Med       Date:  2014-12-16       Impact factor: 3.317

5.  Using different methods to process forced expiratory volume in one second (FEV 1) data can impact on the interpretation of FEV 1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review.

Authors:  Zhe Hui Hoo; Muhaned S A El-Gheryani; Rachael Curley; Martin J Wildman
Journal:  F1000Res       Date:  2018-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.